In the throes of litigation synonymous with one of our time’s most devastating public health crises, Baltimore City has clinched a settlement with pharmaceutical giant Johnson & Johnson just as the civil trial was to unfurl its legal narratives against the company. As it currently stands, the precise details of this agreement remain opaque, shielded from public scrutiny.